Therapeutic potential of dithiocarbamate supported gold compounds

被引:53
作者
Adokoh, Christian K. [1 ]
机构
[1] Univ Cape Coast, Dept Forens Sci, Sch Biol Sci, Coll Agr & Nat Sci, Cape Coast, Ghana
关键词
IN-VITRO CYTOTOXICITY; FACTOR-KAPPA-B; METAL-COMPLEXES; ANTICANCER ACTIVITY; CELL-DEATH; PYRROLIDINE DITHIOCARBAMATE; GOLD(III)-DITHIOCARBAMATO PEPTIDOMIMETICS; PROTEASOME INHIBITORS; TUMOR-CELLS; CANCER;
D O I
10.1039/c9ra09682e
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chrysotherapy or aurotherapy, the use of gold as medicine, is two thousand years old. Hitherto, numerous diverse gold stabilizing ligands for instance vitamins, pyridine, phosphines, naphthylamine and xanthanes have been developed and their 'chelating effect' in addition to their anti-proliferative properties have been extensively studied. Recent advances in the field of bioinorganic chemistry have led to the design of biologically relevant metal complexes with appropriate fine-tuned ligands such as metallic conjugates of dithiocarbamates (DTCs). DTC compounds have been recognised to possess diverse applications and have demonstrated interesting biological properties. For instance, the chemoprotective and antitumour properties of gold metal ions and DTC compounds respectively, presents an innovative and effective approach to cancer management. This review presents therefore the therapeutic potential of DTC ligand systems as a support for gold compounds. The importance of dithiocarbamate supported gold compounds as potential therapeutic agents is highlighted with emphasis on the therapeutic potential of gold(iii) and gold(i) dithiocarbamate derivatives.
引用
收藏
页码:2975 / 2988
页数:14
相关论文
共 98 条
[11]   Exploring the potential of gold(III) cyclometallated compounds as cytotoxic agents: variations on the C∧N theme [J].
Bertrand, B. ;
Spreckelmeyer, S. ;
Bodio, E. ;
Cocco, F. ;
Picquet, M. ;
Richard, P. ;
Le Gendre, P. ;
Orvig, C. ;
Cinellu, M. A. ;
Casini, A. .
DALTON TRANSACTIONS, 2015, 44 (26) :11911-11918
[12]   Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs [J].
Bindoli, Alberto ;
Rigobello, Maria Pia ;
Scutari, Guido ;
Gabbiani, Chiara ;
Casini, Angela ;
Messori, Luigi .
COORDINATION CHEMISTRY REVIEWS, 2009, 253 (11-12) :1692-1707
[13]  
BODENNER DL, 1986, CANCER RES, V46, P2745
[14]   t-Butylsarcosinedithiocarbamato gold(III)-based anticancer agents: Design, in vitro biological evaluation and interaction with model biomolecules [J].
Boscutti, Giulia ;
Feltrin, Lisa ;
Lorenzon, Debora ;
Sitran, Sergio ;
Aldinucci, Donatella ;
Ronconi, Luca ;
Fregona, Dolores .
INORGANICA CHIMICA ACTA, 2012, 393 :304-317
[15]   Pharmaceutical and pharmacological importance of peptide transporters [J].
Brandsch, Matthias ;
Knuetter, Ilka ;
Bosse-Doenecke, Eva .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2008, 60 (05) :543-585
[16]   Metal-recognition by repeating polypeptides [J].
Brown, S .
NATURE BIOTECHNOLOGY, 1997, 15 (03) :269-272
[17]   A genetic analysis of crystal growth [J].
Brown, S ;
Sarikaya, M ;
Johnson, E .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 299 (03) :725-735
[18]   CONTROLLING PLATINUM, RUTHENIUM, AND OSMIUM REACTIVITY FOR ANTICANCER DRUG DESIGN [J].
Bruijnincx, Pieter C. A. ;
Sadler, Peter J. .
ADVANCES IN INORGANIC CHEMISTRY, VOL 61: METAL ION CONTROLLED REACTIVITY, 2009, 61 :1-62
[19]   Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells [J].
Buac, Daniela ;
Schmitt, Sara ;
Ventro, George ;
Kona, Fathima Rani ;
Dou, Q. Ping .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (12) :1193-1201
[20]   Antitumor activity of gold( III)-dithiocarbamato derivatives on prostate cancer cells and xenografts [J].
Cattaruzza, Lara ;
Fregona, Dolores ;
Mongiat, Maurizio ;
Ronconi, Luca ;
Fassina, Ambrogio ;
Colombatti, Alfonso ;
Aldinucci, Donatella .
INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (01) :206-215